Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01859741
Title A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

lung small cell carcinoma

Therapies

Cisplatin

Etoposide

Carboplatin

Tarextumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.